APOA1 and age-related macular degeneration: Although we have detected this mechanism in mice, increased APOA-I levels in the vitreous of AMD patients (Koss et al, 2014) and elevated IL-6 levels with AMD suggest that a similar mechanism is at work in human AMD patients.